Literature DB >> 7553117

Effect of photorefractive keratectomy on visual functioning and quality of life.

C Freitas1, B M Oliveiros, E Marques, E B Leite.   

Abstract

The authors present the results of the psychosocial outcomes of 45 patients undergoing excimer laser photorefractive keratectomy (PRK). The patients were evaluated by means of self-report questionnaires preoperatively and 6 months after surgery to determine the effect of uncorrected vision change on the patients quality of life. The measurements include the following variables: clinical end points (spherical equivalent refraction); visual function (night driving, day driving, near vision, far vision, glare disability); functional status (physical, social, and role functioning, mental status); general well-being (health perceptions, personal well-being, overall quality of life); and satisfaction with surgery (expectations, satisfaction with medical staff, postoperative pain, satisfaction with treatment outcomes). Preliminary results indicate that changes of uncorrected vision after PRK are reflected by improvement in each of the quality-of-life functions.

Entities:  

Mesh:

Year:  1995        PMID: 7553117     DOI: 10.3928/1081-597X-19950502-29

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  4 in total

1.  Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.

Authors:  R P Mills
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Glaucoma patients' assessment of their visual function and quality of life.

Authors:  H D Jampel
Journal:  Trans Am Ophthalmol Soc       Date:  2001

3.  The measurement of patient-reported outcomes of refractive surgery: the refractive status and vision profile.

Authors:  O D Schein
Journal:  Trans Am Ophthalmol Soc       Date:  2000

4.  Quality of life in myopia.

Authors:  K Rose; R Harper; C Tromans; C Waterman; D Goldberg; C Haggerty; A Tullo
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.